
News|Articles|September 2, 2004
- Pharmaceutical Technology-09-02-2004
- Volume 28
- Issue 9
Promoting Quality in Drug Manufacturing
Author(s)Jill Wechsler
FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
Advertisement
Articles in this issue
almost 22 years ago
In the Spotlight-September 2004almost 22 years ago
Automation in a Digital, Webbed, and Wireless Agealmost 22 years ago
September 2004almost 22 years ago
Design of an Aseptic Process Simulationalmost 22 years ago
Early Development Still Driving CRO Performancealmost 22 years ago
Particulate-Free PalletsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Seventeen Peptide Guidance Revised: What Developers Need to Know
2
Quality and Regulations eBook July 2026
3
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
4
European Biotechs Reshaping Respiratory Disease
5




